This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Christer Alstermark
Introduction
Christer Alstermark is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic compounds. His work has been recognized for its potential impact on medical treatments.
Latest Patents
Christer holds a patent for bispidine antiarrhythmic compounds. This patent is crucial as it provides a compound of formula I, which may offer new avenues for treating heart conditions. His innovative approach in this area showcases his commitment to advancing medical science.
Career Highlights
Throughout his career, Christer has been associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes.
Collaborations
Some of his notable coworkers include Annika Björe and Magnus Björsne. Their collaboration has contributed to the success of various projects within the company, enhancing the overall research environment.
Conclusion
Christer Alstermark's contributions to the field of pharmaceuticals, particularly through his patent on bispidine antiarrhythmic compounds, highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire future advancements in medical treatments.